These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24637958)

  • 1. The expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients.
    Su YF; Wu TF; Ko JL; Tsai HT; Tee YT; Chien MH; Chou CH; Lin WL; Low HY; Chou MY; Yang SF; Wang PH
    PLoS One; 2014; 9(3):e91644. PubMed ID: 24637958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
    Wang J; Yi Y; Chen Y; Xiong Y; Zhang W
    Int J Med Sci; 2020; 17(15):2362-2372. PubMed ID: 32922202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.
    Han P; Lin ZR; Xu LH; Zhong Q; Zhu XF; Liang FY; Cai Q; Huang XM; Zeng MS
    Mol Med Rep; 2015 Jul; 12(1):401-9. PubMed ID: 25695839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer.
    Aird KM; Li H; Xin F; Konstantinopoulos PA; Zhang R
    Cell Cycle; 2014; 13(2):199-207. PubMed ID: 24200970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers.
    Huang Y; Liu X; Wang YH; Yeh SD; Chen CL; Nelson RA; Chu P; Wilson T; Yen Y
    Urol Oncol; 2014 Jan; 32(1):51.e9-19. PubMed ID: 24360663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
    Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
    Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2.
    Fang Z; Gong C; Liu H; Zhang X; Mei L; Song M; Qiu L; Luo S; Zhu Z; Zhang R; Gu H; Chen X
    Biochem Biophys Res Commun; 2015 Aug; 464(2):407-15. PubMed ID: 26093293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma.
    Lee B; Ha SY; Song DH; Lee HW; Cho SY; Park CK
    Gut Liver; 2014 Nov; 8(6):662-8. PubMed ID: 25368754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway.
    Shan J; Wang Z; Mo Q; Long J; Fan Y; Cheng L; Zhang T; Liu X; Wang X
    Pancreatology; 2022 Apr; 22(3):401-413. PubMed ID: 35300916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer.
    Wang N; Zhan T; Ke T; Huang X; Ke D; Wang Q; Li H
    Br J Cancer; 2014 Feb; 110(4):1034-44. PubMed ID: 24423925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of catalytic subunit M2 in patients with ovarian cancer.
    Wang LM; Lu FF; Zhang SY; Yao RY; Xing XM; Wei ZM
    Chin Med J (Engl); 2012 Jun; 125(12):2151-6. PubMed ID: 22884145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RRM2 expression in different molecular subtypes of breast cancer and its prognostic significance.
    Abdel-Rahman MA; Mahfouz M; Habashy HO
    Diagn Pathol; 2022 Jan; 17(1):1. PubMed ID: 34986845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer.
    Wu L; Yin L; Ma L; Yang J; Yang F; Sun B; Nianzeng X
    Aging (Albany NY); 2022 Oct; 14(19):7890-7905. PubMed ID: 36202136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma.
    Das B; Jain N; Mallick B
    Gene; 2022 Jan; 808():145988. PubMed ID: 34624457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
    Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
    Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis.
    Ma J; Zhang F; Sun P
    Bioorg Med Chem; 2020 Feb; 28(3):115283. PubMed ID: 31902649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro.
    Morikawa T; Hino R; Uozaki H; Maeda D; Ushiku T; Shinozaki A; Sakatani T; Fukayama M
    Hum Pathol; 2010 Dec; 41(12):1742-8. PubMed ID: 20825972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma.
    Wang S; Wang XL; Wu ZZ; Yang QC; Xiong HG; Xiao Y; Li H; Sun ZJ
    Oral Dis; 2021 Mar; 27(2):204-214. PubMed ID: 32640108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy.
    Fisher SB; Fisher KE; Patel SH; Lim MG; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Farris AB; Maithel SK
    Cancer; 2013 Jan; 119(2):454-62. PubMed ID: 22760605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.
    Zhang H; Liu X; Warden CD; Huang Y; Loera S; Xue L; Zhang S; Chu P; Zheng S; Yen Y
    BMC Cancer; 2014 Sep; 14():664. PubMed ID: 25213022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.